These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3752071)

  • 1. Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: successful treatment of two patients and a review of the literature.
    Ntoso KA; Tomaszewski JE; Jimenez SA; Neilson EG
    Am J Kidney Dis; 1986 Sep; 8(3):159-63. PubMed ID: 3752071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-penicillamine induced crescentic glomerulonephritis: report and review of the literature.
    Devogelaer JP; Pirson Y; Vandenbroucke JM; Cosyns JP; Brichard S; Nagant de Deuxchaisnes C
    J Rheumatol; 1987 Oct; 14(5):1036-41. PubMed ID: 3430507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma. Case report and review of the literature.
    Karpinski J; Jothy S; Radoux V; Levy M; Baran D
    Am J Nephrol; 1997; 17(6):528-32. PubMed ID: 9426850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-penicillamine therapy associated with rapidly progressive glomerulonephritis.
    Macarrón P; García Díaz JE; Azofra JA; Martín de Francisco J; Gonzalez E; Fernandez G; Sampedro J
    Nephrol Dial Transplant; 1992; 7(2):161-4. PubMed ID: 1314978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease.
    Bienaimé F; Clerbaux G; Plaisier E; Mougenot B; Ronco P; Rougier JP
    Am J Kidney Dis; 2007 Nov; 50(5):821-5. PubMed ID: 17954295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilson's disease with reversible renal tubular dysfunction. Correlation with proximal tubular ultrastructure.
    Elsas LJ; Hayslett JP; Spargo BH; Durant JL; Rosenberg LE
    Ann Intern Med; 1971 Sep; 75(3):427-33. PubMed ID: 5315082
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with high-dosage D-penicillamine.
    Sadjadi SA; Seelig MS; Berger AR; Milstoc M
    Am J Nephrol; 1985; 5(3):212-6. PubMed ID: 4014326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphology and pathogenesis of penicillamine-induced nephropathy].
    Henzgen S; Waldmann G
    Zentralbl Allg Pathol; 1983; 128(1-2):53-61. PubMed ID: 6637187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-penicillamine-induced crescentic glomerulonephritis in a patient with scleroderma.
    García-Porrúa C; González-Gay MA; Bouza P
    Nephron; 2000 Jan; 84(1):101-2. PubMed ID: 10644924
    [No Abstract]   [Full Text] [Related]  

  • 10. D-penicillamine-induced ANA (+) ANCA (+) vasculitis in pediatric patients with Wilson's disease.
    Lee Y; Lee ST; Cho H
    Clin Nephrol; 2016 May; 85(5):296-300. PubMed ID: 26784915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal glomerulitis due to penicillamine.
    Hayslett JP; Bensch KG; Kashgarian M; Rosenberg LE
    Lab Invest; 1968 Oct; 19(4):376-81. PubMed ID: 5699118
    [No Abstract]   [Full Text] [Related]  

  • 12. Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature.
    Derk CT; Jimenez SA
    J Rheumatol; 2003 Jul; 30(7):1616-20. PubMed ID: 12858467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glomerulopathy due to D-penicillamine--clinical findings and renal biopsy].
    Brass H; Genth E; Hartl PW; Bauerdick H; Buss H; Lapp H; Heintz R
    Med Welt; 1976 Nov; 27(45):2151-3. PubMed ID: 994834
    [No Abstract]   [Full Text] [Related]  

  • 14. [Membranous glomerulonephritis caused by D-penicillamine].
    Bécares Lozano MM; Pascual Izuel JM; Mateos Sánchez A; Delgado Martínez J; Querol Prieto R; Flores Corral T
    Rev Clin Esp; 1982 Mar; 164(6):411-2. PubMed ID: 7111809
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic lupus erythematosus-like syndrome with focal proliferative glomerulonephritis during D-penicillamine therapy.
    Donnelly S; Levison DA; Doyle DV
    Br J Rheumatol; 1993 Mar; 32(3):251-3. PubMed ID: 8448620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilson's disease treated with penicillamine and lupus erythematosus: related or distinct entities?
    Dell'era L; Boati E; Nebbia G; Corona F
    Minerva Pediatr; 2012 Feb; 64(1):55-7. PubMed ID: 22350045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1 inhibitor deficiency in a patient with rheumatoid arthritis--increased risk of adverse effects of penicillamine?
    Sturfelt G; Rydgren L; Truedsson L; Alm P; Sjöholm AG
    J Rheumatol; 1996 Feb; 23(2):378-81. PubMed ID: 8882051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus erythematosus-like eruption due to D-penicillamine in progressive systemic sclerosis.
    Tsankov NK; Lazarova AZ; Vasileva SG; Obreshkova EV
    Int J Dermatol; 1990 Oct; 29(8):571-4. PubMed ID: 2147020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penicillamine-induced rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis.
    Almirall J; Alcorta I; Botey A; Revert L
    Am J Nephrol; 1993; 13(4):286-8. PubMed ID: 8267029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapidly progressive glomerulonephritis with D-penicillamine.
    Nanke Y; Akama H; Terai C; Kamatani N
    Am J Med Sci; 2000 Dec; 320(6):398-402. PubMed ID: 11149553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.